Evidence map›Paper›PMID 40823769›Full record

ArticleBioanalysis2025

17th GCC Closed Forum: Integrative Bioanalysis, Patient-centric Sampling, Emerging Technologies, Data Integrity, Sample Reconciliation, Discrepancies of ELISpot Data, Cross-validation Harmonization, Ultrasensitive Platforms for ADA Assays, Remote Regulatory Assessments, Shedding Assays by PCR, and Biomarker Tissue Assays.

Jennifer Zimmer, Mark O'dell, Derrick Johnson, Amanda Hays, Shashank Gorityala, Magdalena Tary-Lehmann, Katherine Malone, Manisha Diaz, Tao Xu, Varun Dwivedi and 37 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioanalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Jennifer ZimmerAlturas Analytics, Inc., Moscow, Idaho, USA.
Mark O'dellB2S Life Sciences, Franklin, Indiana, USA.
Derrick JohnsonB2S Life Sciences, Franklin, Indiana, USA.
Amanda HaysBioAgilytix Labs, Durham, North Carolina, USA.
Shashank GorityalaBioAgilytix Labs, Morrisville, North Carolina, USA.
Magdalena Tary-LehmannCellular Technology Ltd, Shaker Heights, Ohio, USA.
Katherine MaloneCharles River Laboratories, Reno, Nevada, USA.
Manisha DiazEurofins Viracor BioPharma Services, San Antonio, Texas, USA.
Tao XuFrontage Laboratory, Exton, Pennsylvania, USA.
Varun DwivediKCAS Bio, Spring house, Pennsylvania, USA.
Dawn DufieldKCAS Bio, Olathe, Kansas, USA.
Tracy IlesLabcorp, Harrogate, UK.
Daniel SikkemaLabcorp, Chantilly, Virginia, USA.
Ritankar MajumdarLabcorp, Chantilly, Virginia, USA.
Nathan RiccitelliNavigate BioPharma Services, Inc., Carlsbad, California, USA.
Moucun YuanPPD, Part of Thermo Fisher Scientific, Henrico, Virginia, USA.
Steve LowesIQVIA, Ithaca, New York, USA.
Aihua LiuResolian, Malvern, Pennsylvania, USA.
Katie MatysIQVIA, Ithaca, New York, USA.
Annelies TurksmaSanquin Diagnostic Services, Amsterdam, Netherlands.
John PirroSword Bio, Long Branch, New Jersey, USA.
Jerome BergeronSyneos Health, Quebec City, Quebec, Canada.
Shane KarnikAliri Bioanalysis, Colorado Springs, Colorado, USA.
Troy VoelkerAliri Bioanlysis, Salt Lake City, Utah, USA.
Danielle SalhaAltasciences, Laval, Quebec, Canada.
Gregory ReynoldsBioAgilytix Labs, San Diego, California, USA.
Corbyn LamyCharles River Laboratories, Shrewsbury, Massachusetts, USA.
Mathilde YuCIRION BioPhama Research Inc, a Cerba Research Company, Laval, Quebec, Canada.
Wei GarofoloGCC, Toronto, Ontario, Canada.
Sankeetha NadarajahGCC, Toronto, Ontario, Canada.
Amanda LeskovarICON, Whitesboro, New York, USA.
Mario PellerinICON, Whitesboro, New York, USA.
Rathna VeeramachaneniKCAS Bio, Olathe, Kansas, USA.
Cheikh KaneKCAS Bio, Olathe, Kansas, USA.
Allan XuKeystone Bioanalytical, Inc., North Wales, Pennsylvania, USA.
Elizabeth HyerLabcorp, Madison, Wisconsin, USA.
Annika CarlssonMercodia AB, Uppsala, Sweden.
Mitesh SanghviPharmaron, Germantown, Maryland, USA.
Elizabeth DompkowskiPPD, Part of Thermo Fisher Scientific, Henrico, Virginia, USA.
Stephen RundlettPrecision for Medicine, Redwood City, California, USA.
Joseph BowerPrecision for Medicine, Frederick, Maryland, USA.
Adriane SpytkoIQVIA, Ithaca, New York, USA.
Jia LiuShanghai Xihua Scientific Co., Ltd., Shanghai, China.
Weihua GuShanghai Xihua Scientific Co., Ltd., Shanghai, China.
Agostinho RochaSmithers, Ewing, New Jersey, USA.
Kyla O'BrienSyneos Health, Princeton, New Jersey, USA.
Xinping FangTri-Apex Laboratories Inc., North Wales, Pennsylvania, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 17th GCC Closed Forum was held in San Antonio, TX, USA, on 10

Indexed as

BiomarkersEnzyme-Linked Immunospot AssayPolymerase Chain ReactionData AccuracyHumansBiomarkersBioanalysisbiomarker tissue assaysCROcross-validationELISpotGCCGlobal CRO Councilimmunogenicity assaysPatient-centric samplingqPCR/dPCRSample ReconciliationShedding assays

Identifiers

PMID40823769
PMCPMC12367079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.